Marijuana rescheduling not on agenda ‘at this time’

The Trump administration won’t reclassify the status of marijuana under federal law anytime soon.

That’s according to an unidentified White House official who told CNN this week that “no action is being considered at this time” on rescheduling.

The statement comes despite President Donald Trump having expressed his support for marijuana reform while on the campaign trail.

The White House official’s comment came as a pro-legalization political action committee, American Rights and Reform PAC, announced a $1 million ad campaign.

The PAC said it will pay to broadcast 30-second commercials in support of marijuana reform on cable and streaming services in markets where Trump, an avid television consumer, is apt to see them – in Washington, D.C., and near his Mar-a-Lago home in Florida.

The PAC, formerly called Legalize America, is bankrolled by major multistate operators.

According to campaign finance records, the PAC had roughly $390,000 on hand at the end of 2024, the most recent data available.

The top donors were:

• Chicago-based MSO Cresco Labs, which contributed $250,000.
• New York-headquartered Curaleaf Holdings, which gave $50,000.

Many smaller donations came from the US Cannabis Roundtable, formerly known as the U.S. Cannabis Council.

Direct involvement from Trump, no matter the impetus, is considered to be the best hope for federal marijuana reform such as rescheduling.

That process was put on hold in January by the U.S. Drug Enforcement Administration’s chief administrative law judge.

Trump’s seeming embrace of marijuana rescheduling inspired optimism among marijuana multistate operators, some of whom attended his January inauguration.

However, the president’s actions since then have poured cold water over that initial enthusiasm:

And the Trump administration’s proposal to slash university research budgets would stymie those very efforts, academics say.